glp-1 coverage insurance news Medicare Drug The GLP-1 Access Gap: Mapping

[DOI] [PubMed] [Google Scholar] 36.Edison P

Innovation in Oral Obesity Drug Design: Analyses the transition from conventional weight loss medicines to innovative oral GLP-1 agonists, dual incretin agonists, triple agonists, amylin and small molecule obesity drug classes

Horowitz M, Cook DJ, Collins PJ et al (1982) Measurement of gastric emptying after gastric bypass surgery using radionuclides

Gudbergsen H, Henriksen M, Waehrens EE, Overgaard A, Bliddal H, Christensen R, Boesen MP, Knop FKK, Astrup A, Rasmussen MU, Bartholdy C, Daugaard C, Bartels EM, Ellegaard K, Heitmann BL, Kristensen LE (2019) Effect of liraglutide on body weight and pain in patients with overweight and knee osteoarthritis: protocol for a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial

The GLP-1 component does what researchers already know GLP-1 agonists do